Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1 beta levels

---

Copy For Citation

Yalcin A. D., ÇİLLİ A., Bisgin A., Strauss L. G., Herth F.

EXPERT OPINION ON BIOLOGICAL THERAPY, vol.13, no.9, pp.1335-1341, 2013 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 13 Issue: 9
• Publication Date: 2013
• Doi Number: 10.1517/14712598.2013.819338
• Journal Name: EXPERT OPINION ON BIOLOGICAL THERAPY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.1335-1341
• Çukurova University Affiliated: Yes

Abstract

Background: There have been concerns about the cardiovascular safety of omalizumab.